Literature DB >> 6025919

Oral administration of methylene blue to patients with renal calculi.

W H Boyce, W M McKinney, T T Long, G W Drach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6025919     DOI： 10.1016/s0022-5347(17)63117-3

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Inhibition of oxalate nephrolithiasis with Ammi visnaga (AI-Khillah).

Authors:  Z A Khan; A M Assiri; H M Al-Afghani; T M Maghrabi
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  The inhibitory effect of phenothiazine stains on rat and guinea-pig mast cell damage induced by antihistamines and compound 48-80.

Authors:  I Vugman; M L do Prado
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  The effect of pH and urine dilution on the electrophoretic mobility of uric acid crystals.

Authors:  S I Ismail; R Tawashi; Z Ismail
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

4.  Methylene blue as an inhibitor of stone formation.

Authors:  K Ahmed; R Tawashi
Journal:  Urol Res       Date:  1978

5.  Primary hyperoxaluria.

Authors:  P F O'Regan; A M Joekes
Journal:  J R Soc Med       Date:  1980-08       Impact factor: 18.000

Review 6.  Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.

Authors:  Claude M Wischik; Björn O Schelter; Damon J Wischik; John M D Storey; Charles R Harrington
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.